Transcutaneous posterior tibial nerve stimulation versus extended release oxybutynin in overactive bladder patients. A prospective randomized trial
- 1 January 2016
- journal article
- research article
- Published by Elsevier in European Journal of Obstetrics & Gynecology and Reproductive Biology
- Vol. 196, 6-10
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Transcutaneous posterior tibial nerve stimulation: evaluation of a therapeutic option in the management of anticholinergic refractory overactive bladderInternational Urogynecology Journal, 2014
- An international urogynecological association (IUGA)/international continence society (ICS) joint report on the terminology for female pelvic floor dysfunctionNeurourology and Urodynamics, 2009
- Randomized Trial of Percutaneous Tibial Nerve Stimulation Versus Extended-Release Tolterodine: Results From the Overactive Bladder Innovative Therapy TrialJournal of Urology, 2009
- Discontinuation Rates of Anticholinergic Medications Used for the Treatment of Lower Urinary Tract SymptomsObstetrics & Gynecology, 2008
- Population-Based Survey of Urinary Incontinence, Overactive Bladder, and Other Lower Urinary Tract Symptoms in Five Countries: Results of the EPIC StudyEuropean Urology, 2006
- Correlation between quality of life and voiding variables in patients treated with percutaneous tibial nerve stimulationBJU International, 2005
- Antimuscarinic Drugs for Overactive Bladder and Their Potential Effects on Cognitive Function in Older PatientsJournal of the American Geriatrics Society, 2005
- Posterior tibial nerve stimulation in the treatment of voiding dysfunction: Urodynamic dataNeurourology and Urodynamics, 2004
- Prevalence and burden of overactive bladder in the United StatesWorld Journal of Urology, 2003
- Posterior tibial nerve stimulation in the treatment of urge incontinenceNeurourology and Urodynamics, 2002